Topics and Expertise: Eukaryotic Cells

Gartner named one of Popular Science’s “Brilliant 10” of 2015

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.

Zev Gartner, PhD, has focused on the next best thing: His lab is...